Through a largely successful Prevention-of-Mother-to-Child-Transmission (PMTCT) programme undertaken by the National Department of Health, and in collaboration with various private and non-profit partners, the rate of child HIV infection has significantly decreased in recent years. But the battle is far from over.
World Health Organisation Recommendations
Earlier this year, the World Health Organisation (WHO) put forward a global recommendation that antiretroviral treatment be offered to every person diagnosed with HIV. Recent clinical trials have shown that starting treatment sooner rather than later, can not only prolong the life of an HIV-infected patient but also reduce the risk of them infecting their partners. While the updated WHO Guidelines emphasise the effectiveness of beginning treatment soon after diagnosis, there remains the issue of treatment availability. Our global goal of enabling easy access to antiretroviral treatment and preventing medical stockouts, especially in South Africa, is still a concern.
New Vaccine Trials
The search for an effective HIV vaccine continues unabated, with global effort having concentrated on this for many years. As reported by Health-E News in October 2015, a new, rather novel vaccine trial will include women in Sub-Saharan Africa, and will begin rolling out during the first quarter of 2016.
World AIDS Day 2015
The World AIDS Day theme for 2011 to 2015, focuses on “Getting To Zero”, with previous campaigns having focused on getting to zero new infections, eliminating discrimination and preventing HIV/AIDS-related deaths. If you’d like to participate in World AIDS Day, why not get tested? You can find a nearby testing site by searching the info4africa database of health and welfare service providers, calling the National AIDS Helpline or getting involved in a HIV and AIDS programme at your workplace.
Register on LifeDoc™, take your test and upload the results certificate with ease. Register here or like the LifeDoc™ Facebook page for regular updates. You can also stay on track with LifeDoc™ developments on Twitter.